The safety study on the first treatment of sEST combined with EPBD in elderly patients with choledocholithiasis
Objective To investigate the clinical effect and safety of the first endoscopic retrograde cholan-giopancreatography(ERCP)treatment in elderly patients with choledocholithiasis.Methods Clinical data of patients with choledocholithiasis underwent endoscopic retrograde cholangiopancreatography(ERCP)+endo-scopic sphincterotomy(sEST)+Endoscopic papillary balloon dilation(EPBD)for the first time who admitted to the First Affiliated Hospital of Anhui University of Science & Technology from January 2019 to August 2023 were retrospectively analyzed.According to the age of the patients,the patients were divided into the eld-erly group and the non-elderly group,the age of the elderly group ≥70 years old,and the age of the non-elder-ly group＜70 years old.The clinical data of patients with choledocholithiasis were compared between the two groups,and the clinical effect and postoperative complications of ERCP+sEST+EPBD in the treatment of eld-erly patients with choledocholithiasis were analyzed.Results There were significant differences in age,pre-operative comorbidities,choledocholithiasis removal rate,and biliary stent in the elderly group compared with the non-elderly group(P＜0.05).There was no significant difference in postoperative complications between the two groups(P＞0.05),and there were statistically significant differences in preoperative oral platelet drugs and intubation times ≥2 times between the two groups(P＜0.05).Conclusion The first use of ER-CP+sEST+EPBD for elderly patients with choledocholithiasis is safe,but the removal rate of choledocholithi-asis is lower than that in non-elderly patients.For patients with oral platelet drugs and intubation times≥2 times before surgery,the occurrence of postoperative complications should be noticed.
choledocholithiasischolangiopancreatography,endoscopic retrogradesphincterotomy,en-doscopeold people
万方数据
维普
